Aerie Pharmaceuticals to be sold for $770M

Alcon, a Switzerland-based eye care company, is teed up to acquire Durham, N.C.-based Aerie Pharmaceuticals for about $770 million after approval from each company’s board of directors Aug. 22. 

Advertisement

Aerie Pharmaceuticals specializes in testing, manufacturing and selling eye treatments. 

Pending stockholder approval, the transaction is expected to finalize in the fourth quarter of 2022, according to a news release.

Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit

Advertisement

Next Up in Pharmacy

Advertisement

Comments are closed.